Pelage Pharmaceuticals

About Pelage Pharmaceuticals

Pelage Pharmaceuticals is a company focused on developing regenerative medicines for hair loss, grounded in stem cell biology. Their mission is to deliver clinically-tested, FDA-approved treatments that target hair follicle stem cells to stimulate hair growth for all genders, skin types, and hair types, addressing conditions like androgenetic alopecia, drug-induced alopecia, and telogen effluvium.

Products & Services

PP405:A breakthrough topical, non-invasive small molecule treatment designed to reactivate dormant hair follicle stem cells, restoring hair growth in balding areas. It targets a metabolic switch in stem cells and is non-hormonal, suitable for all genders and hair types.

PP405

Specialties

Regenerative Medicine Stem Cell Biology Hair Loss Treatment Topical Drug Development regenerative medicine hair loss treatment stem cell activation androgenetic alopecia non-invasive topical therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 120000000 MR: - FA: 120 million FAN: 120000000	D: 2025-10-15 FD: 2025-10-15	5 investors
2	RT: Series A T: - FT: Series A	A: 16750000 MR: - FA: 16.75M FAN: 16750000	D: 2024-02-27 FD: 2024-02-27	4 investors

Series B Latest

2025-10-15

$120.0M

5 investors (Pro only)

Series A 2024-02-27

$16.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Daniel Gil

Chief Executive Officer

C

Christina Weng

Chief Medical Officer

N

Nathan Wheeler

Chief Operating Officer

W

William Lowry

President & Co-Founder

M

Maykin Ho

Board Member

L

Lisa Sherman

Vice President, Head of Clinical Operations

View 5 more team members with Pro

Unlock Full Team Directory

Recent News